跳至主要内容
临床试验/CTRI/2024/05/066653
CTRI/2024/05/066653尚未招募Unknown

To determine the efficacy of outpatient antimicrobial therapy (OPAT) with Liposomal amphotericin B in invasive sinonasal mucurmycosis, a randomised controlled trial - NI

All India Institute of Medical Sciences, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient giving written informed consent
  • All stable cases of invasive sinonasal mucormycosis (orbital, minimal intracranial extension included), after initial management with surgical debridement and medical therapy.
  • Patient with local residence/ ready for commute.
  • Good cognition and family support
  • Stable - Clinical improvement;
  • No major infusion reaction requiring stopping of drug administration
  • Adequate intake, output, blood parameters (S. K+, elctrolytes, S. creatinine, Urea) for the past 72 hours

排除标准

  • Not consenting
  • Gross residual disease after debridement
  • Lack of family support and cognition
  • Unable to commute or do not have local residence

研究者

发起方
All India Institute of Medical Sciences, New Delhi

相似试验